Barclays Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $40
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper (NASDAQ:KDP) and raises the price target from $37 to $40.
July 28, 2023 | 10:25 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays maintains an Overweight rating on Keurig Dr Pepper and raises the price target from $37 to $40, which could lead to a positive market reaction.
The raised price target by Barclays indicates a positive outlook for Keurig Dr Pepper. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100